These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1979515)

  • 1. CRF-like effects of sauvagine and urotensin I on synaptosomal tyrosine hydroxylase activity of mouse striatum.
    Onali P; Olianas MC
    Brain Res; 1990 Sep; 526(2):181-5. PubMed ID: 1979515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of corticotropin-releasing factor-stimulated adenylate cyclase activity in rat retina.
    Olianas MC; Onali P
    J Neurochem; 1990 Jun; 54(6):1967-71. PubMed ID: 2159980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
    Lenz HJ; Fisher LA; Vale WW; Brown MR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor-like peptides increase cytosolic [Ca2+] in human epidermoid A-431 cells.
    Kiang JG
    Eur J Pharmacol; 1997 Jun; 329(2-3):237-44. PubMed ID: 9226418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of synaptosomal dopamine synthesis by corticotropin-releasing factor in rat striatum: role of Ca2+-dependent mechanisms.
    Olianas MC; Onali P
    Eur J Pharmacol; 1989 Jul; 166(2):165-74. PubMed ID: 2477258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the behavioral effects of CRF, sauvagine and urotensin I.
    Britton DR; Hoffman DK; Lederis K; Rivier J
    Brain Res; 1984 Jun; 304(2):201-5. PubMed ID: 6611193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor activates tyrosine hydroxylase in rat and mouse striatal homogenates.
    Olianas MC; Onali P
    Eur J Pharmacol; 1988 Jun; 150(3):389-92. PubMed ID: 2901359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.
    Rivier C; Rivier J; Lederis K; Vale W
    Regul Pept; 1983 Jan; 5(2):139-43. PubMed ID: 6298906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amunine (ovine CRF), urotensin I and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation.
    MacCannell KL; Lederis K; Hamilton PL; Rivier J
    Pharmacology; 1982; 25(2):116-20. PubMed ID: 6982480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol inhibits the ACTH-releasing activity of urotensin I, CRF and sauvagine observed with superfused goldfish pituitary cells.
    Fryer J; Lederis K; Rivier J
    Peptides; 1984; 5(5):925-30. PubMed ID: 6095221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies.
    Perrin MH; Tan LA; Vaughan JM; Lewis KA; Donaldson CJ; Miller C; Erchegyi J; Rivier JE; Sawchenko PE
    J Pharmacol Exp Ther; 2015 May; 353(2):307-17. PubMed ID: 25736419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urotensin I, a CRF-like neuropeptide, stimulates acth release from the teleost pituitary.
    Fryer J; Lederis K; Rivier J
    Endocrinology; 1983 Dec; 113(6):2308-10. PubMed ID: 6315348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
    Martinez V; Barquist E; Rivier J; Taché Y
    Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the thermogenic effects of CRF, sauvagine and urotensin I in the rat.
    Le Feuvre RA; Rothwell NJ; White A
    Horm Metab Res; 1989 Sep; 21(9):525-6. PubMed ID: 2583676
    [No Abstract]   [Full Text] [Related]  

  • 15. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
    Heldwein KA; Redick DL; Rittenberg MB; Claycomb WC; Stenzel-Poore MP
    Endocrinology; 1996 Sep; 137(9):3631-9. PubMed ID: 8756527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of corticotropin releasing factor and sauvagine on food intake.
    Gosnell BA; Morley JE; Levine AS
    Pharmacol Biochem Behav; 1983 Nov; 19(5):771-5. PubMed ID: 6359178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation using microphysiometry of CRF receptor pharmacology.
    Smart D; Coppell A; Rossant C; Hall M; McKnight AT
    Eur J Pharmacol; 1999 Aug; 379(2-3):229-35. PubMed ID: 10497910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of corticotropin releasing factor and sauvagine on social behavior of isolated mice.
    Mele A; Cabib S; Oliverio A; Melchiorri P; Puglisi-Allegra S
    Peptides; 1987; 8(5):935-8. PubMed ID: 3501578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity.
    Dautzenberg FM; Huber G; Higelin J; Py-Lang G; Kilpatrick GJ
    Neuropharmacology; 2000 Jun; 39(8):1368-76. PubMed ID: 10818253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.